Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Treatment of thalassaemia major with phenylbutyrate and hydroxyurea.

Olivieri NF, Rees DC, Ginder GD, Thein SL, Brittenham GM, Waye JS, Weatherall DJ.

Lancet. 1997 Aug 16;350(9076):491-2. No abstract available.

PMID:
9274590
2.
3.
4.
5.

Efficacy of hydroxyurea (HU) in reduction of pack red cell (PRC) transfusion requirement among children having beta-thalassemia major: Karachi HU trial (KHUT).

Ansari SH, Shamsi TS, Siddiqui FJ, Irfan M, Perveen K, Farzana T, Panjwani VK, Yousuf A, Mehboob T.

J Pediatr Hematol Oncol. 2007 Nov;29(11):743-6.

PMID:
17984691
6.

The activity of superoxide dismutase in hydroxyurea-treated E beta thalassemia.

Ajanta H, Chakraborty S, Madhusnata D, Bhattacharya DK, Manisha D.

J Assoc Physicians India. 2002 Aug;50:1034-5.

PMID:
12421025
7.

Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia.

Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L.

Am J Hematol. 1999 Dec;62(4):221-7.

8.

Use of hydroxyurea and recombinant erythropoietin in management of homozygous beta0 thalassemia.

Kohli-Kumar M, Marandi H, Keller MA, Guertin K, Hvizdala E.

J Pediatr Hematol Oncol. 2002 Dec;24(9):777-8.

PMID:
12468925
9.

Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.

Italia KY, Jijina FF, Chandrakala S, Nadkarni AH, Sawant P, Ghosh K, Colah RB.

J Clin Pharmacol. 2010 Feb;50(2):231-4. doi: 10.1177/0091270009343933. Epub 2009 Oct 1. No abstract available.

PMID:
19797538
10.

The XmnI and BCL11A single nucleotide polymorphisms may help predict hydroxyurea response in Iranian β-thalassemia patients.

Banan M, Bayat H, Azarkeivan A, Mohammadparast S, Kamali K, Farashi S, Bayat N, Khani MH, Neishabury M, Najmabadi H.

Hemoglobin. 2012;36(4):371-80. doi: 10.3109/03630269.2012.691147. Epub 2012 Jun 11.

PMID:
22686296
11.

Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome.

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP; E/beta Thalassaemia Study Group.

Br J Haematol. 2005 Nov;131(3):378-88.

PMID:
16225658
12.

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

J Clin Pathol. 2010 Feb;63(2):147-50. doi: 10.1136/jcp.2009.070391.

PMID:
20154037
13.

Hydroxyurea therapy in 49 patients with major beta-thalassemia.

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Arch Iran Med. 2009 May;12(3):295-7.

14.

Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.

Voskaridou E, Terpos E, Komninaka V, Eftyhiadis E, Mantzourani M, Loukopoulos D.

Br J Haematol. 2002 Jan;116(1):155-7.

PMID:
11841409
15.

The role of hydroxyurea in sickle cell disease.

Halsey C, Roberts IA.

Br J Haematol. 2003 Jan;120(2):177-86. Review. No abstract available. Erratum in: Br J Haematol. 2003 Apr;121(1):200.

PMID:
12542474
16.

Update on the use of hydroxyurea therapy in sickle cell disease.

Wong TE, Brandow AM, Lim W, Lottenberg R.

Blood. 2014 Dec 18;124(26):3850-7; quiz 4004. doi: 10.1182/blood-2014-08-435768. Epub 2014 Oct 6. Review. No abstract available.

17.

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Ann N Y Acad Sci. 2005;1054:250-6.

PMID:
16339672
18.

Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.

Koren A, Segal-Kupershmit D, Zalman L, Levin C, Abu Hana M, Palmor H, Luder A, Attias D.

Pediatr Hematol Oncol. 1999 May-Jun;16(3):221-32.

PMID:
10326220
19.

[Study of hemoglobinopathies found in Belgium].

Fondu P.

Bull Mem Acad R Med Belg. 1995;150(10-11):367-75; discussion 376-8. French.

PMID:
8845787
20.

Elimination of transfusions through induction of fetal hemoglobin synthesis in Cooley's anemia.

Olivieri NF, Rees DC, Ginder GD, Thein SL, Waye JS, Chang L, Brittenham GM, Weatherall DJ.

Ann N Y Acad Sci. 1998 Jun 30;850:100-9.

PMID:
9668532

Supplemental Content

Support Center